skip to main
|
skip to sidebar
生技
Thursday, July 15, 2010
vvus减肥药被拒
US advisers reject Vivus' fat pill; shares plunge
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
Resources
关注榜
生物谷
汤姆森科技信息
新药发展动态
fiercebiotech
EP Vantage
gekkowire
Labels
ALTH
(1)
AMGN
(1)
AMLN
(1)
AMRN
(1)
ARIA
(2)
ARNA
(1)
ATHX
(1)
AVEO
(1)
AVNR
(1)
BIIB
(1)
CHPI
(1)
CLDX
(3)
CMED
(1)
CSKI
(1)
DNDN
(7)
EXEL
(2)
HALO
(3)
HGSI
(5)
HLCS
(6)
ICGN
(1)
IMGN
(1)
IMMU
(2)
INCY
(15)
ISPH
(2)
ITMN
(4)
JGBO
(1)
KERX
(2)
MITI
(2)
MNKD
(4)
MYGN
(1)
NKBP
(2)
NYMX
(4)
ONTY
(1)
ONXX
(1)
OPK
(1)
OREX
(2)
PARD
(1)
PRE/VIEW
(2)
RIGL
(2)
SCR
(1)
SGEN
(11)
SPPI
(1)
SVA
(1)
TRGT
(9)
TTNP.PK
(1)
VNDA
(1)
VPHM
(2)
VRTX
(2)
VVUS
(7)
WATCHLIST
(2)
XNPT
(4)
XOMA
(1)
ZGEN
(2)
Search This Blog
Blog Archive
►
2011
(16)
►
May
(1)
►
April
(9)
►
March
(3)
►
January
(3)
▼
2010
(35)
►
December
(6)
►
September
(1)
▼
July
(6)
天一药业被疑做假，股价一路下滑
FDA受理Mannkind重新提交的AFREZZA新药上市申请
vvus减肥药被拒
VVUS风险大, 不要赌通过
Sanofi 传说要收购美国公司
Dendreon重挫, 逢低吸纳
►
June
(2)
►
May
(7)
►
April
(3)
►
March
(4)
►
February
(1)
►
January
(5)
►
2009
(55)
►
December
(9)
►
November
(2)
►
October
(22)
►
September
(20)
►
June
(1)
►
March
(1)
Followers
No comments:
Post a Comment